HNRNPA2B1 and hepatocellular carcinoma: Several studies have shown that increased hnRNPA2B1 expression in HCC patients is significantly associated with a poorly differentiated tumor stage and is an independent prognostic factor for HCC patients (Cui et al., 2010; Mizuno et al., 2012).